JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
Revionics to Speak and Exhibit at RetailTECH X in Australia
-
MINDBODY Files Registration Statement for Proposed Initial Public Offering
-
Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2015 Financial Results
-
OvaScience Reports First Quarter 2015 Financial Results
-
Notable Analyst Rating Changes 5/11: (CSCO) (RCL) (Z) Upgraded; (NTAP) (ETSY) (MNKD) Downgraded
-
JMP Securities Starts GoDaddy Inc (GDDY) at Market Outperform
-
Cepheid to Webcast Upcoming Financial Presentations
-
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2015
-
JMP Securities Downgrades OraSure Technologies (OSUR) to Market Perform
-
HTG Molecular Diagnostics (HTGM) Prices 3.57M Common IPO at $14/Share
-
HTG Molecular Diagnostics Announces Pricing of Initial Public Offering
-
HTG Molecular Diagnostics Announces Pricing of Initial Public Offering
-
Flex Pharma Reports First Quarter 2015 Financial Results
-
Blueprint Medicines Announces Closing of Initial Public Offering
-
JMP Securities Sees Material Bottom-Line 'Beat' for Medivation (MDVN)
-
Notable Analyst Rating Changes 5/5: (NFLX) (ALU) (ARRS) Upgraded; (BIDU) (AOL) (GNW) Downgraded
-
New Immuno-Oncology Conference Announced for NYC Combining Business and Clinical Development Strategies
-
JMP Securities Starts Synchrony Financial (SYF) at Market Outperform
-
Auris Medical Holding AG Announces Proposed Public Offering of Common Shares
-
Corbus Pharmaceuticals to Present at the Cystic Fibrosis Workshop Hosted by JMP Securities on May 8, 2015
-
Fortress Transportation and Infrastructure Investors LLC Announces Launch of Initial Public Offering
-
Fortress Transportation and Infrastructure Investors LLC Announces Launch of Initial Public Offering
-
JMP Securities Upgrades Cash America International (CSH) to Market Outperform
-
NephroGenex (NRX) to Offer Up to $30M in Common Stock
-
NephroGenex Announces Proposed Offering of Common Stock
-
Blueprint Medicines (BPMC) IPO Opens Up 30%
-
Blueprint Medicines Announces Pricing of Initial Public Offering
-
ProQR to Present at Two Upcoming Investor Conferences in May
-
ProQR to Present at Two Upcoming Investor Conferences in May
-
JMP Securities Downgrades Marvell (MRVL) to Market Underperform
-
Unusual 11 Mid-Day Movers 4/28: (AMCO) (WIN) (SCL) Higher; (UNXL) (MDCA) (EIGI) Lower
-
JMP Group Names Co-Heads of Healthcare Investment Banking
-
JMP Securities Upgrades ServiceSource International (SREV) to Market Outperform
-
Apigee (APIC) IPO Opens Up 18%
-
JMP Group Reports First Quarter 2015 Financial Results
-
JMP Securities Downgrades Ubiquiti Networks (UBNT) to Market Perform
-
Apigee Announces Pricing of Initial Public Offering
-
Apigee Announces Pricing of Initial Public Offering
-
Scynexis (SCYX) Prices 4.68M Common Shares at $7.70/Share
-
JMP Securities Downgrades Informatica (INFA) to Market Perform
-
SCYNEXIS Announces Pricing of Public Offering of Common Stock
-
Akebia Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
JMP Group to Report First Quarter Financial Results on April 24, 2015
-
JMP Securities Starts Bovie Medical (BVX) at Market Outperform
-
WatchGuard Technologies Wins Most Innovative Firewall and Cutting Edge SIEM Solution from Cyber Defense Magazine
-
SCYNEXIS Announces Launch of Public Offering of Common Stock
-
Blackstone Mortgage Trust Announces Closing of Public Offering of Class A Common Stock and Full Exercise of Option by Underwriters
-
UPDATE: JMP Securities Starts CyberArk Software (CYBR) at Market Outperform
-
Notable Analyst Rating Changes 4/17: (PENN) (XEL) (EMC) Upgraded; (IPXL) (GS) (MT) Downgraded
-
Akebia Therapeutics (AKBA) Prices 7.27M Common Offering at $8.25/Share

